New Drugs : Spinosad
Spinosad 0.9% provides new scabies option With Christopher Belcher, MD Amid a climate of increasing drug resistance, the April 2021 approval of Spinosad 0.9% (Natroba, ParaPRO) for scabies gives practitioners a novel prescription option with high efficacy and safety. “This should be viewed as a very exciting development in the treatment of scabies. Given the […]